Curbstone Financial Management Corp Gilead Sciences, Inc. Transaction History

Curbstone Financial Management Corp

$458 Million
Q3 2024

A detailed history of Curbstone Financial Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Curbstone Financial Management Corp holds 5,640 shares of GILD stock, worth $522,151. This represents 0.1% of its overall portfolio holdings.

Number of Shares

5,640

Holding current value

$522,151

% of portfolio

0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$66.59 - $83.99 $375,567 - $473,703	5,640 New	5,640 $472,000
Q4 2023 Jan 08, 2024	SELL	$73.27 - $83.09 $8,792 - $9,970	-120 Reduced 2.1%	5,590 $452,000
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $15,462 - $17,616	-200 Reduced 3.38%	5,710 $473,000
Q4 2022 Jan 19, 2023	BUY	$62.32 - $89.47 $368,311 - $528,767	5,910 New	5,910 $507,000
Q1 2022 Apr 18, 2022	SELL	$57.92 - $72.58 $349,836 - $438,383	-6,040 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$64.88 - $73.64 $9,083 - $10,309	140 Added 2.37%	6,040 $439,000
Q2 2021 Jul 09, 2021	SELL	$63.47 - $69.35 $55,853 - $61,027	-880 Reduced 12.98%	5,900 $406,000
Q1 2021 Apr 05, 2021	BUY	$60.0 - $68.46 $406,800 - $464,158	6,780 New	6,780 $438,000
Q3 2019 Oct 18, 2019	SELL	$62.51 - $69.0 $1.02 Million - $1.12 Million	-16,270 Closed	0 $0
Q2 2019 Jul 09, 2019	BUY	$61.87 - $69.38 $40,215 - $45,097	650 Added 4.16%	16,270 $1.1 Million
Q1 2019 Apr 10, 2019	SELL	$62.53 - $70.05 $136,315 - $152,709	-2,180 Reduced 12.25%	15,620 $1.02 Million
Q4 2018 Jan 09, 2019	SELL	$60.54 - $79.0 $345,078 - $450,300	-5,700 Reduced 24.26%	17,800 $1.11 Million
Q4 2018 Jan 08, 2019	BUY	$60.54 - $79.0 $154,377 - $201,450	2,550 Added 12.17%	23,500 $1.67 Million
Q3 2018 Oct 10, 2018	SELL	$71.28 - $78.92 $181,764 - $201,246	-2,550 Reduced 10.85%	20,950 $1.62 Million
Q2 2018 Jul 06, 2018	SELL	$64.88 - $75.68 $32,439 - $37,840	-500 Reduced 2.08%	23,500 $1.67 Million
Q1 2018 Apr 10, 2018	BUY	$72.84 - $88.8 $904,308 - $1.1 Million	12,415 Added 107.16%	24,000 $1.81 Million
Q4 2017 Jan 08, 2018	SELL	$71.15 - $83.52 $1.18 Million - $1.39 Million	-16,585 Reduced 58.87%	11,585 $830,000
Q3 2017 Oct 03, 2017	BUY	$72.11 - $85.47 $2.03 Million - $2.41 Million	28,170	28,170 $2.28 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.

Account

Curbstone Financial Management Corp Gilead Sciences, Inc. Transaction History